News
-
-
-
-
-
-
-
-
PRESS RELEASE
Formycon and Fresenius Kabi announce the commercial launch of FYB202/Otulfi™, an approved ustekinumab biosimilar in Canada
Formycon and Fresenius Kabi announce commercial launch of FYB202/Otulfi ustekinumab biosimilar in Canada, expanding treatment options for chronic autoimmune diseases -
-
PRESS RELEASE
Volcon ePowersports Receives Purchase Order from Advanced EV for 1,000 Golf Carts and Resumes Share Repurchase Program
Volcon ePowersports receives first purchase order of 1,000 golf carts from Advanced EV for market testing of new model, signaling future collaboration. Resumes share repurchase program